- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- BMA- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.12: 10 residues within 4Å:- Chain C: S.211, E.213, P.214, V.256, L.263, N.264, G.380, V.446, S.447
- Ligands: NAG.44
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:V.446
NAG-NAG-BMA-MAN-MAN-MAN.20: 10 residues within 4Å:- Chain G: S.211, E.213, L.263, N.264, C.379, I.439, Q.440, V.446, S.447
- Ligands: NAG.57
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:V.446
- 42 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.24: 4 residues within 4Å:- Chain A: E.89, N.90
- Chain B: G.8, S.9
Ligand excluded by PLIPNAG.25: 7 residues within 4Å:- Chain A: N.236, T.238, S.276, E.277, N.278, I.279
- Ligands: NAG.27
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: D.232, K.233, N.243
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain A: N.278, I.279, T.280, N.281
- Ligands: NAG.25
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain A: N.340, W.396
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain A: Q.295, N.297, R.444
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain A: N.264, S.293, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN-MAN-BMA-MAN.4
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain A: N.303, I.324
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain A: Q.132, S.152, F.153, N.154
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain A: R.194, N.199, T.200
- Chain C: R.310
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain A: N.135, K.149
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: G.355, N.356
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain A: E.270, N.291, E.292
Ligand excluded by PLIPNAG.37: 5 residues within 4Å:- Chain A: N.364, S.365, S.389
- Ligands: NAG-NAG.2, NAG-NAG.2
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.99
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: K.114, E.115, N.118
Ligand excluded by PLIPNAG.40: 5 residues within 4Å:- Chain C: N.236, T.238, G.239, S.276, E.277
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain C: N.243
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: N.278, N.281
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: N.340, E.341, W.396
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: N.264, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.12
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: N.303, I.324, V.442
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain C: Q.132, S.152, F.153, N.154
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain C: N.199
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain C: N.135
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain C: R.351, G.355, N.356
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain C: E.270, N.291, K.345
Ligand excluded by PLIPNAG.51: 7 residues within 4Å:- Chain C: N.364, S.365, S.366, T.373
- Ligands: NAG-NAG.8, NAG-NAG.9, NAG-NAG.9
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain D: E.115, N.118, Y.119
Ligand excluded by PLIPNAG.53: 6 residues within 4Å:- Chain G: N.236, T.238, S.276, E.277, N.278, I.279
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain G: T.242, N.243
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain G: N.278, T.280, N.281
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain G: N.340, T.395, W.396
Ligand excluded by PLIPNAG.57: 4 residues within 4Å:- Chain G: N.264, S.293, N.448
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.20
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain G: N.303, I.324, V.442
Ligand excluded by PLIPNAG.59: 6 residues within 4Å:- Chain G: V.136, N.138, N.150, Y.167, L.169, D.322
Ligand excluded by PLIPNAG.60: 4 residues within 4Å:- Chain G: Q.132, S.152, F.153, N.154
Ligand excluded by PLIPNAG.61: 5 residues within 4Å:- Chain G: N.135, R.145, G.146, Q.177, Y.193
Ligand excluded by PLIPNAG.62: 1 residues within 4Å:- Chain G: N.356
Ligand excluded by PLIPNAG.63: 4 residues within 4Å:- Chain G: E.270, E.271, N.291, E.292
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain H: N.99, S.101, E.102
Ligand excluded by PLIPNAG.65: 2 residues within 4Å:- Chain H: N.118, Y.119
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP.v5.2 N241/N289 - gp120: ACG
BG505 SOSIP.v5.2 N241/N289 - gp41: BDH
Rh.33311 pAbC-4 - Heavy Chain: E
Rh.33311 pAbC-4 - Light Chain: F - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CG
EB
BD
DH
FE
HF
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 20 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- BMA- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 42 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP.v5.2 N241/N289 - gp120: ACG
BG505 SOSIP.v5.2 N241/N289 - gp41: BDH
Rh.33311 pAbC-4 - Heavy Chain: E
Rh.33311 pAbC-4 - Light Chain: F - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CG
EB
BD
DH
FE
HF
L